* SINGULAIR (Montelukast, MSD) 10 mg Adult 14 Tablets. * Indications: Singulair is indicated in adult and pediatric patients 6 months of age and older for the prophylaxis && chronic treatment & & of asthma, including the prevention od day- and nighttime symptoms, th treatment of aspirin-sensitive asthmatic patients, & & and the prevention of excercise-induced bronchoconstriction. Singulair is indicated for the relief of daytime and nighttime symptoms & & of allergic rhinitis (seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older). * Dosage && Administration: & & – Singulair should be taken once daily. For asthma, the dose should be taken in the evening. For allegic rhinitis, the time of & & administration may be individualized to suit patient needs. & & – Patients with both asthma and allergic rhinitis should take only one tablet daily in the evening. & & – Adults 15 years of age and older with asthma and/or seasonal allergic rhinitis: one 10-mg tablet daily. & & – Pediatric patients 6 to 14 years of age with asthma and/or seasonal allergic rhinitis: 5-mg chewable tablet daily. & & – Pediatric patients 2 to 5 years of age with asthma and/or seasonal allergic rhinitis: one 4-mg chewable tablet daily or one packet & & of 4-mg oral granules daily. & & – Pediatric patients 6 months to 2 years of age with asthma: one packet of 4-mg oral granules daily. * To be dispensed by or on the prescription of physician. * Store in a dry place, at temperature between 15-30 degrees C, protected from moisture && light. * Produced by: Global Napi Pharmaceuticals (GNP) – Egypt. & & Under license from: Merck && Co. Inc., Whitehouse Station, N.J., USA && its subsidiary in UK. (MSD) & & Registered trademark of Merck && Co. Inc., Whitehouse Station, N.J., USA.